HR Execs on the Move

Seasons

www.seasons.org

 
Seasons Hospice & Palliative Care (SHPC) is a community-based organization with an ongoing mission to find creative solutions that add quality to end-of-life care. The caregivers at SHPC hold steadfast to the patient/family focus of hospice care. We recognize that individuals and families are the experts in their own care, and we continuously strive for excellence beyond accepted standards. We are born into a world of comfort, warmth and love, and it our belief that we should all leave this world in the same way. To further that goal, we work with communities to increase the awareness of hospice as ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $10-50 Million
  • www.seasons.org
  • 6400 Shafer Court Suite 700
    Rosemont, IL USA 60018
  • Phone: 847.692.1000

Executives

Name Title Contact Details
Carl Brodarick
 Chief Marketing Officer Profile
Charneth Pfeiffer
 National Director of Human Resources Profile
Sarah McKinnon
 Senior Vice President of Employee Experience and Organizational Development Profile
Melissa Strecansky
 Director - Human Resources Profile

Similar Companies

Complete Senior Care

Complete Senior Care is a Niagara Falls, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Texas Healthcare PLLC

Texas Healthcare PLLC is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Fort Worth, TX. To find more information about Texas Healthcare PLLC, please visit www.txhealthcare.com

Sherman Health Systems

Sherman Health Systems is a Elgin, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Most Products Inc

Most Products Inc is a Plainwell, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Foghorn Therapeutics

More than 20,000 genes make us human. Genes control critical aspects of health and disease — but what controls our genes? Foghorn® Therapeutics ($FHTX) is developing therapies based on a system that directs which genes our cells express, and when, where, and in what order. By manipulating this system with our unique Gene Traffic Control™ platform, Foghorn will change how genes turn “on” and “off.” Unlike approaches that edit genes, this novel way of thinking will alter what our DNA has in store for us—and rewrite destiny for millions of people living with disease. With Gene Traffic Control™ Foghorn is pioneering a new, major class of drug targets to develop unprecedented therapies for cancer and other serious diseases. We have already validated multiple targets, are in the process of developing drug candidates in multiple types of cancer and are beginning to explore other diseases.